What Centessa Pharmaceuticals plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 8 | 35 |
| Total trades | 24 | 86 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 86 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 10% owner | Jun 24 | Sale for tax withholding · S | −281,162 | — | — | 0 |
| Medicxi Ventures Management (Jersey) Ltd | 10% owner | Jun 24 | Sale for tax withholding · S | −11,197,303 | — | — | 0 |
| Medicxi Ventures Management (Jersey) Ltd | 10% owner | Jun 24 | Sale for tax withholding · S | −93,526 | — | — | 0 |
| Medicxi Ventures Management (Jersey) Ltd | 10% owner | Jun 24 | Sale for tax withholding · S | −3,936,970 | — | — | 0 |
| Medicxi Ventures Management (Jersey) Ltd | 10% owner | Jun 24 | Sale for tax withholding · S | −55,677 | — | — | 0 |
| Medicxi Ventures Management (Jersey) Ltd | 10% owner | Jun 24 | Sale for tax withholding · S | −4,398,519 | — | — | 0 |
| Index Ventures Life Vi (JERSEY) L.p. | 10% owner | Jun 24 | Sale for tax withholding · S | −149,421 | — | — | 0 |
| Index Ventures Life Vi (JERSEY) L.p. | 10% owner | Jun 24 | Sale for tax withholding · S | −9,812,368 | — | — | 0 |
| Weinhoff Gregory M | Chief Business Officer | Jun 24 | Disposition to Issuer · D | −65,925 | — | — | 0 |
| Goyal Arjun | Director | Jun 24 | Disposition to Issuer · D | −462,585 | — | — | 0 |
| De Rubertis Francesco | Director | Jun 24 | Disposition to Issuer · D | −281,162 | — | — | 0 |
| De Rubertis Francesco | Director | Jun 24 | Disposition to Issuer · D | −11,197,303 | — | — | 0 |
| De Rubertis Francesco | Director | Jun 24 | Disposition to Issuer · D | −93,526 | — | — | 0 |
| De Rubertis Francesco | Director | Jun 24 | Disposition to Issuer · D | −3,936,970 | — | — | 0 |
| De Rubertis Francesco | Director | Jun 24 | Disposition to Issuer · D | −55,677 | — | — | 0 |
| De Rubertis Francesco | Director | Jun 24 | Disposition to Issuer · D | −4,398,519 | — | — | 0 |
| Accardi Mario Alberto | Chief Executive Officer | Jun 24 | Disposition to Issuer · D | −243,282 | — | — | 0 |
| Kanes Stephen | Chief Medical Officer | Jun 24 | Disposition to Issuer · D | −120,000 | — | — | 0 |
| Deferiere Raphael | Chief Accounting Officer | Jun 24 | Disposition to Issuer · D | −11,000 | — | — | 0 |
| Anderson Karen M. | Chief People Officer | Jun 24 | Disposition to Issuer · D | −62,085 | — | — | 0 |
Loading...
